Noveltreat 0.5 mg Pre-Filled Pen is a product of semaglutide 0.5mg/0.5mL. Semaglutide is the active ingredient and a GLP-1 receptor agonist in its chemical composition and mechanism of action. Together with a low-calorie and high-protein diet plus physical activity, these can help support weight loss and weight maintenance.
It is a weight management treatment that can be taken once daily as an injection under the skin. This product is available in the form of pre-filled pens in different doses: 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg.
What is Noveltreat 0.5 mg used for?
Noveltreat 0.5 mg injection is a kind of weight loss medication containing semaglutide which is used for the treatment of obesity on a long-term basis.
This medication is prescribed for managing weight gain of a person over a prolonged period of time, along with a low-calorie diet and physical activity.
Semaglutide may help:
- Reduce hunger
- Increase feelings of fullness
- Reduce food cravings
- Help control portion sizes
- Lower overall calorie intake
- Support gradual weight loss
- Support long-term weight maintenance
This medication is meant to complement rather than replace a comprehensive weight lose plan which includes proper diet and regular physical exercise.
How does It work?
Noveltreat contains semaglutide, which acts on GLP-1 receptors.
GLP-1 is a hormone involved in appetite regulation, digestion and blood glucose control. Semaglutide mimics some of its effects and can:
- Reduce appetite
- Increase satiety
- Reduce hunger
- Slow gastric emptying
- Reduce food intake
- Help with weight management
These effects may make it easier to follow a reduced-calorie eating plan.
Dosage
0.5mg once weekly is generally the next dose after the 0.25mg starting dose.
The Noveltreat weight-management range follows a gradual dose-escalation approach:
| Treatment stage | Weekly semaglutide dose |
|---|---|
| Starting dose | 0.25mg |
| Early escalation | 0.5mg |
| Further escalation | 1mg |
| Further escalation | 1.7mg |
| Maintenance dose | 2.4mg |
Do not move from 0.25mg to 0.5mg or increase beyond 0.5mg without your healthcare professional’s instructions.
How to use Noveltreat 0.5 mg Pre-Filled Pen
Noveltreat 0.5 mg is given as a subcutaneous injection once a week.
It is injected under the skin, commonly in the:
- Abdomen
- Thigh
- Upper arm
It should not be injected into a vein or muscle.
Important points
- Use Noveltreat exactly as prescribed.
- Take the injection once weekly.
- Try to use the same day each week.
- The injection can generally be taken with or without food.
- Rotate injection sites when appropriate.
- Check the pen before use.
- Do not use a damaged pen.
- Do not share the pen with another person.
The Noveltreat 0.5mg shown is a single-dose pre-filled pen. The supplied pack should be checked for its exact number of pens. Australian Wegovy’s comparable 0.5mg fixed-dose pen is also a single-use pen containing one dose.
Can Noveltreat 0.5mg be taken with food?
Yes. Because Noveltreat is injected under the skin, it does not require fasting.
It can generally be administered regardless of meals. What matters more is adherence to the recommended once-weekly plan.
It is different for instance from oral semaglutide tablets such as Rybelsus, which require very specific fasting and water intake conditions.
When does Noveltreat 0.5mg start working?
Semaglutide starts working immediately after you take it; however, the appetite effects and the changes in body weight are a progressive thing.
Some people may find that their hunger decreases or that they become full more quickly within the first few weeks of taking the medicine, while for others the changes can be quite subtle and even gradual.
The 0.5mg dose is still in the dosage ramp-up part, therefore, it shouldn’t be seen solely through the speed of weight loss.
Different people react differently to loss of weight.
What if you miss a Noveltreat 0.5mg dose?
According to the Australian Wegovy drug information, for losing weight through semaglutide, if you miss a dose of Wegovy, you can generally take it any time within the following 5 days.
If it has been over 5 days since your last dose of Wegovy, don’t take the missed Injection as a make-up dose, and do your next Injection on the regular day as always.
If you Missed several doses in a row, Talk to your doctor first when you want to resume, because sometimes a lower dose may be adequate.
Common side effects
Digestive side effects are common with semaglutide, especially during the dose-escalation period.
Possible side effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal pain or discomfort
- Bloating
- Indigestion
- Headache
- Reduced appetite
- Dizziness
The symptoms may become more noticeable after moving to a higher dose and may become less troublesome as the body adjusts.
When should you seek medical attention?
Contact a healthcare professional if you experience:
- Severe or persistent abdominal pain
- Repeated vomiting
- Severe diarrhoea
- Signs of dehydration
- Symptoms of gallbladder disease
- A serious allergic reaction
- Sudden or significant changes in vision
Severe abdominal pain can be a warning sign of pancreatitis. Persistent vomiting or diarrhoea can cause dehydration and may affect kidney function.
The TGA has also issued safety information regarding the rare eye condition non-arteritic anterior ischaemic optic neuropathy (NAION) associated with GLP-1 receptor agonists. Sudden vision loss requires urgent medical assessment.
Precautions
Tell your doctor if you have or have previously had:
- Pancreatitis
- Gallstones or gallbladder disease
- Severe gastrointestinal problems
- Gastroparesis or delayed stomach emptying
- Kidney disease
- Liver disease
- Diabetic retinopathy
- A serious allergy to semaglutide
- Medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Your doctor should also know about all prescription medicines, supplements and herbal products you take.
Extra care may be required if you use insulin or sulfonylureas because combining them with semaglutide can increase the risk of low blood glucose.
Noveltreat 0.5 mg and pregnancy
Noveltreat is a medicine that should not be used during pregnancy because no information is available about its effects in human pregnancy.
Couples trying to get pregnant are advised to seek consultation from a doctor about the use of semaglutide since it is generally believed by scientists that semaglutide crosses the placenta and can harm the developing fetus. Also, in Australia, the semaglutide product information advises discontinuation of treatment at least 2 months before pregnancy is conceived.
You should consult a medical professional if you discover pregnancy while you are under Noveltreat treatment.
Noveltreat 0.5 mg interactions
Tell your doctor about all medicines, vitamins and supplements you take.
Semaglutide slows gastric emptying and may affect the absorption of some oral medicines.
Particular attention may be needed with:
- Insulin
- Sulfonylureas
- Other diabetes medicines
- Other GLP-1 receptor agonists
- Other semaglutide-containing products
- Medicines requiring careful monitoring
Do not combine Noveltreat with another semaglutide product or GLP-1 receptor agonist unless specifically instructed by your doctor.
Noveltreat 0.5 mg and surgery
Tell your surgeon and anaesthetist that you are taking semaglutide before an operation or procedure involving general anaesthesia or deep sedation.
Semaglutide delays gastric emptying, which can be relevant during anaesthesia because stomach contents may remain present despite standard fasting.
Australian regulators have issued safety information about the potential aspiration risk associated with GLP-1 medicines.
Your medical team will advise you about how your treatment should be managed before the procedure.
How to store Noveltreat 0.5 mg
Noveltreat 0.5 mg should be stored in a refrigerator at 2°C to 8°C.
Important storage instructions include:
- Do not freeze.
- Protect the pen from direct light.
- Keep it in the original carton.
- Keep it out of the reach of children.
- Do not use it after the expiry date.
If the pen has been frozen or exposed to temperatures outside the recommended range, ask your pharmacist whether it can still be used.
Noveltreat 0.5 mg and weight management
For instance, It is just the starting low dose of the drug Noveltreat that is later increased to maintenance dose in the case of standard Noveltreat usage.
At 0.5mg some people may feel less hungry, while others may see slower weight loss. Diet, the amount of exercise done, the length of the treatment, how fat a person was to begin with and their personal reaction to the drug are among the variables that affect the level of weight loss.
The reason for dose increment is to achieve good effect with limited side effects (i.e., better tolerability, not to cause weight reduction overnight).
Frequently Asked Questions
1. Can Noveltreat 0.5 mg be injected on a different day each week?
This particular injection should generally be given once a week. If for some reason you would like to change your regular day for the injection, talk to your medical staff about the best way of timing it. They can help you. Don’t change your injection schedule repeatedly without professional advice.
2. Can Noveltreat 0.5 mg cause constipation even if I am eating less?
The fact is, constipation is a gastrointestinal side effect that is well known with semaglutide. Eating smaller amounts can affect bowel movements. Drinking enough fluids and talking to your healthcare provider about continuing constipation may be effective.
3. Can I exercise normally while using Noveltreat 0.5 mg?
Physical activity plays a vital role in weight management. Noveltreat is designed to be taken alongside a greater amount of physical activity and a diet lower in calories. If you experience nausea, dizziness or major digestive symptoms, discuss with your doctor about the possibility of changing your activity for a while.
4. What happens if I accidentally inject Noveltreat 0.5 mg twice in one week?
You shouldn”t take another dose of the drug before you have discussed it with a medical professional. Taking an extra dose could lead to more serious or additional side effects such as nausea, sickness, vomiting and diarrhea.
References
- TGA – Wegovy FlexTouch 0.5mg, ARTG 424391 (Therapeutic Goods Administration (TGA))
- TGA – Wegovy 0.5mg Pre-Filled Pen, ARTG 356285 (Therapeutic Goods Administration (TGA))
- TGA – Wegovy Australian Product Information (Therapeutic Goods Administration (TGA))
- Healthdirect Australia – Wegovy (Healthdirect)
Medical disclaimer: This information is for educational purposes only and does not replace advice from a doctor or pharmacist. Always follow the prescription, current product information and instructions supplied with your medicine.
